Posts

• Penumbra’s Newly Expanded swiftPAC^™ Coil Line Poised to Help Physicians Meet Growing Demand for Neurosurgical Conditions (June 20, 2025)
• Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial (June 16, 2025)
• New THRIVE Data Demonstrates Penumbra’s CAVT^™ Technology Is Associated with Reduced Related Readmissions and Complication Rates When Managing ALI (June 6, 2025)
• Penumbra Introduces the Ruby® XL System – the Longest, Largest, and Softest Coil on the Market for Vascular Embolization (June 5, 2025)
• Employee Spotlight: Maria R. Contreras (May 29, 2025)
• Penumbra, Inc. to Present at Upcoming Investor Conferences (May 20, 2025)
• Trial Finds Penumbra’s RED 43 Aspiration Catheter Safe and Effective for Thrombectomy of Distal Medium Vessel Occlusions in Acute Ischemic Stroke (May 12, 2025)
• How Stroke Survivors Are Thriving with Advanced Care (May 8, 2025)
• Penumbra Launches STRIDE II Clinical Study to Further Evaluate Penumbra’s CAVT Technology for Lower Extremity Acute Limb Ischemia (May 7, 2025)
• Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference (April 29, 2025)
• Employee Spotlight: Shirin Azizi (April 24, 2025)
• Penumbra, Inc. Reports First Quarter 2025 Financial Results (April 23, 2025)
• Announcing RED^® 72 SILVER LABEL — Now Featuring Penumbra's Latest Engineering Enhancements Designed for Seamless Navigation (April 23, 2025)
• MIND IDE Trial of Penumbra’s Artemis Neuro Evacuation Device Shows Potential Promise for Patients Experiencing Hemorrhagic Stroke (April 22, 2025)
• Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 (April 3, 2025)
• Lightning Bolt^® Technology Restores Blood Flow in Rutherford 2b Limb Ischemia (April 2, 2025)
• Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits (April 2, 2025)
• Patient Story: Amelia Litterio (March 31, 2025)
• Employee Spotlight: Silvana Loo (March 27, 2025)
• Computer Assisted Vacuum Thrombectomy (CAVT^™): Revolutionizing Frontline Blood Clot Care (March 27, 2025)
• The Get Out the Clot Campaign Honors Blood Clot Awareness Month with a New Patient Pledge (March 24, 2025)
• Latest Data on Penumbra’s CAVT Technology to Be Presented at SIR 2025: STRIDE, STRIKE-PE, and More (March 17, 2025)
• Employee Spotlight: Donald Rich (February 27, 2025)
• Penumbra Launches ACCESS25^™ Delivery Microcatheter Designed for Aneurysm Access and Delivery of Elevated Clinical Benefits (February 26, 2025)
• Lightning Bolt^™ 7 Case Study: Restoring Flow to an Occluded Renal Artery with Computer Assisted Vacuum Thrombectomy (CAVT^™) (February 24, 2025)
• Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors (February 21, 2025)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (February 18, 2025)
• Penumbra Launches Element^™ Vascular Access System – the First Laser-Cut Hypotube Sheath Designed for Venous Thromboembolism (January 29, 2025)
• Employee Spotlight: Guadalupe Gutierrez (January 28, 2025)
• Lightning Bolt^® 6X with TraX^™ Case Study: Revascularization of Tibioperoneal Artery with Computer Assisted Vacuum Thrombectomy (CAVT^™) (January 27, 2025)
• Announcing Lightning Bolt^® 12 and Lightning Bolt 6X with TraX^™ – Newest Additions to Penumbra’s CAVT^™ Platform for the Management of Arterial and Venous Thrombus (January 22, 2025)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025 (January 21, 2025)
• Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference (December 30, 2024)
• Employee Spotlight: Louie Gnida (December 23, 2024)
• Employee Spotlight: Aditi Kolla (November 26, 2024)
• Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference (November 20, 2024)
• Lightning Bolt^® 7 Case Study: Rapid Revascularization of Bilateral Renal Artery Occlusion with Computer Assisted Vacuum Thrombectomy (CAVT^™) (November 5, 2024)
• New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options (November 5, 2024)
• Penumbra, Inc. Reports Third Quarter 2024 Financial Results (October 30, 2024)
• Employee Spotlight: Esteban Zendejas (October 25, 2024)
• Latest Findings from Penumbra’s STRIKE-PE Study to be Presented at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) Conference (October 24, 2024)
• Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke (October 14, 2024)
• Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism (October 10, 2024)
• Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 (October 2, 2024)
• Employee Spotlight: Joanna Kur (September 27, 2024)
• Recent Data Show Positive Outcomes of Penumbra’s BENCHMARK™ BMX®81 System for Radial Access during Neurovascular Interventions (September 16, 2024)
• Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies – Lightning Flash™ 2.0 and Lightning Bolt™ 7 – in Europe (September 16, 2024)
• Employee Spotlight: Jermel Price (August 29, 2024)
• North Carolina Stroke Survivor Gets Second Act Thanks to Wife’s Awareness of Need to Act FAST (August 28, 2024)
• Penumbra Expands STRIKE-PE Study to 1500 Patients (August 27, 2024)
• Penumbra, Inc. to Present at the Baird Global Healthcare Conference (August 27, 2024)
• Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference (August 21, 2024)
• One-year Data Demonstrate Firstline Mechanical Thrombectomy with Penumbra’s Indigo^®️ Aspiration System Yields High Limb Salvage Rates and Improved Quality of Life for Patients with LE-ALI (August 20, 2024)
• Penumbra, Inc. Announces $200 Million Share Repurchase Authorization (August 13, 2024)
• Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference (August 2, 2024)
• Penumbra, Inc. Reports Second Quarter 2024 Financial Results (July 30, 2024)
• Employee Spotlight: Audrey Muck (July 26, 2024)
• Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 (July 2, 2024)
• Employee Spotlight: Dexter Whack (June 28, 2024)
• Latest STRIKE-PE Data Published in JVIR Showing that Penumbra’s Computer Assisted Vacuum Thrombectomy Technology For Pulmonary Embolism Improved Patient Outcomes (June 25, 2024)
• 101-Year-Old Stroke Survivor Shares Story in Hopes of Helping Others (June 24, 2024)
• Penumbra Announces European Launch of its Most Advanced Neuro Access Offerings: BMX81 and BMX96 (June 17, 2024)
• Penumbra Announces European Launch of its Most Advanced Neuro Access Offerings: BMX81 and BMX96 (June 17, 2024)
• Penumbra, Inc. to Present at the Truist Securities MedTech Conference (June 4, 2024)
• Penumbra, Inc. to Present at the William Blair Growth Stock Conference (May 23, 2024)
• Employee Spotlight: Mitchel Kinghorn (May 23, 2024)
• Penumbra, Inc. Reports First Quarter 2024 Financial Results (May 7, 2024)
• Penumbra Launches Latest Innovations in Neuro Embolization Intervention: MIDWAY™ Intermediate Catheters (May 7, 2024)
• Penumbra Expands Stroke Portfolio in Europe (May 7, 2024)
• Penumbra Expands Stroke Portfolio in Europe (May 7, 2024)
• Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference (May 1, 2024)
• This Survive Stroke Week – Know the Important Signs and Symptoms to Survive and Thrive (April 30, 2024)
• Employee Spotlight: Jacquel Prazych (April 23, 2024)
• Penumbra Launches Lightning Flash 2.0 – Latest CAVT Technology Designed to Rapidly Remove Blood Clots (April 23, 2024)
• Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 (April 9, 2024)
• Employee Spotlight: Jeremiah Christie (March 28, 2024)
• New Data Show Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Used in a Single-Session Without Overnight Thrombolytics Is Safe and Effective for Patients with LE-ALI (March 27, 2024)
• Launch of EMBOLIZE Clinical Trial Is First-of-its-kind Study to Explore Treatment for Pelvic Venous Disorders (March 25, 2024)
• Employee Spotlight: Meenakshi Mattu (February 29, 2024)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (February 22, 2024)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024 (February 1, 2024)
• New STRIDE Data on Aspiration Thrombectomy Show No Sex Differences in Target Limb Salvage Rates in Lower Extremity ALI Patients (January 29, 2024)
• Employee Spotlight: Rafael Fideles (January 22, 2024)
• Penumbra Launches Indigo^™ System CAT^™ RX Catheter in Europe to Address Acute Coronary Syndrome (January 12, 2024)
• Penumbra Launches Indigo^™ System CAT^™ RX Catheter in Europe to Address Acute Coronary Syndrome (January 12, 2024)
• Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference (December 19, 2023)
• Employee Spotlight: Phillip Smith Jr. (December 18, 2023)
• Employee Spotlight: Kale Cordero (November 28, 2023)
• First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy – Lightning Flash™ – for Treatment of Acute Pulmonary Embolism (November 28, 2023)
• Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference (November 14, 2023)
• Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans (November 10, 2023)
• Penumbra, Inc. Reports Third Quarter 2023 Financial Results (November 2, 2023)
• New Late Breaking Data Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy Technology For Pulmonary Embolism Improved Patient Outcomes (November 1, 2023)
• Celebrating National Physical Therapy Month (October 26, 2023)
• Employee Spotlight: Mars Jokela (October 24, 2023)
• 2023 World Thrombosis Day (October 12, 2023)
• Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023 (October 5, 2023)
• Employee Spotlight: Meet Jacob Zepeda (September 19, 2023)
• Penumbra, Inc. to Present at Upcoming Investor Conferences (August 23, 2023)
• Employee Spotlight: Meet Andrea Hoffman (August 22, 2023)
• Penumbra, Inc. Reports Second Quarter 2023 Financial Results (August 1, 2023)
• Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference (July 26, 2023)
• Employee Spotlight: Meet Gyan Bhatia (July 19, 2023)
• Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023 (July 5, 2023)
• Employee Spotlight: Meet Shyam Kuppurathanam (June 15, 2023)
• Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration (June 1, 2023)
• Employee Spotlight: Meet Jemy Allen (May 31, 2023)
• Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference (May 24, 2023)
• New Data Demonstrates Indigo Aspiration System Improves ALI Patient Outcomes – STRIDE Study (May 3, 2023)
• Penumbra, Inc. Reports First Quarter 2023 Financial Results (May 2, 2023)
• Employee Spotlight: Meet Megan Loy (April 6, 2023)
• Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023 (April 4, 2023)
• Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality (April 4, 2023)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (February 23, 2023)
• Employee Spotlight: Meet Nancy Thao (February 22, 2023)
• Penumbra, Inc. to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference (February 16, 2023)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023 (January 26, 2023)
• Employee Spotlight: Meet Daniel Escobar (January 13, 2023)
• Penumbra Launches Latest Innovation in Mechanical Thrombectomy: Lightning Flash^™ (January 10, 2023)
• Penumbra, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference (December 19, 2022)
• Employee Spotlight: Meet Gigi San Juan (November 18, 2022)
• Penumbra Launches First Hands-Free, Full Body Virtual Reality-Based Offering for Rehabilitation, Expanding REAL^® System Platform (November 15, 2022)
• Penumbra, Inc. Reports Third Quarter 2022 Financial Results (November 3, 2022)
• Penumbra, Inc. to Present at the Jefferies London Healthcare Conference (November 1, 2022)
• Employee Spotlight: Meet Greg J. Hakanson (October 12, 2022)
• Penumbra, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 3, 2022 (October 6, 2022)
• Penumbra and Asahi Intecc Partner With Goal of Introducing Indigo™ System Including Lightning™ Intelligent Aspiration to Japan (September 22, 2022)
• Penumbra Announces European Launch of RED® Reperfusion Catheters for Stroke Care (September 7, 2022)
• Latest Data Demonstrates Penumbra System and RED® Reperfusion Catheters Effective for Broad Stroke Care (August 25, 2022)
• Why Representation Matters: <p>Q&A with Dr. Elizabeth Genovese (August 19, 2022)
• Penumbra, Inc. Reports Second Quarter 2022 Financial Results (August 4, 2022)
• Penumbra, Inc. to Present at the Canaccord Genuity 42nd Annual Growth Conference (July 27, 2022)
• Penumbra, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022 (July 7, 2022)
• Employee Spotlight: Meet Durga Devi (June 14, 2022)
• Penumbra, Inc. Reports First Quarter 2022 Financial Results (May 3, 2022)
• Penumbra, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference (April 26, 2022)
• Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration (April 14, 2022)
• Penumbra, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 3, 2022 (April 5, 2022)
• National Doctors Day (March 30, 2022)
• Penumbra, Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference (March 28, 2022)
• Employee Spotlight: Meet Norem Soriano (March 14, 2022)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results (February 22, 2022)
• Penumbra, Inc. to Present at Citi's 2022 Virtual Healthcare Conference (February 10, 2022)
• Employee Spotlight: Meet Faye Titchenal (February 1, 2022)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 22, 2022 (February 1, 2022)
• Health: January Is National Blood Donor Month (January 26, 2022)
• Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference (December 22, 2021)
• New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra's Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome (November 5, 2021)
• Penumbra, Inc. Reports Third Quarter 2021 Financial Results (November 3, 2021)
• Penumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 (October 6, 2021)
• Penumbra Acquires Sixense Enterprises (October 4, 2021)
• Penumbra, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference (August 31, 2021)
• Penumbra, Inc. to Present at the 2021 Wells Fargo Virtual Healthcare Conference (August 26, 2021)
• Penumbra Introduces REAL® i-Series™, Expanding REAL Immersive System to Support Broad Range of Care Providers and Mental Health Professionals (August 10, 2021)
• Penumbra, Inc. Reports Second Quarter 2021 Financial Results (August 9, 2021)
• Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference (July 28, 2021)
• Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021 (July 12, 2021)
• Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients (June 23, 2021)
• Penumbra, Inc. to Present at the William Blair 41st Annual Growth Stock Virtual Conference (May 18, 2021)
• Penumbra, Inc. Reports First Quarter 2021 Financial Results (May 4, 2021)
• Penumbra, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference (April 27, 2021)
• Penumbra, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 4, 2021 (April 13, 2021)
• Penumbra Announces U.S. Commercial Availability of INDIGO System Lightning 7 (March 18, 2021)
• Meetings & Events: Penumbra Announces Participation at IVRHA's Annual Symposium (February 26, 2021)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results (February 23, 2021)
• Penumbra, Inc. to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference (February 10, 2021)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 23, 2021 (February 2, 2021)
• Penumbra Affirms Original Clinical Research Authored by Co-Founder and Chief Innovator Dr. Arani Bose (January 12, 2021)
• Penumbra Announces Preliminary Unaudited Revenue for the Fourth Quarter and Full Year 2020 (January 11, 2021)
• Penumbra Announces Penumbra JET 7 Reperfusion Catheter with Xtra Flex Technology Voluntary Recall (December 15, 2020)
• Penumbra Responds to False Allegations from Short Sellers Seeking to Manipulate Company Stock and Remove Life-saving Medical Devices from the Market (December 8, 2020)
• Penumbra, Inc. to Participate in CEO Discussion with Bank of America (December 4, 2020)
• Penumbra's Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism (November 20, 2020)
• Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism (November 10, 2020)
• Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum (November 6, 2020)
• Penumbra, Inc. Reports Third Quarter 2020 Financial Results (October 28, 2020)
• Penumbra, Inc. Schedules Third Quarter 2020 Earnings Release and Conference Call for October 28, 2020 (September 29, 2020)
• Penumbra, Inc. to Present at the Morgan Stanley 18th Annual Global Healthcare Conference (September 3, 2020)
• Penumbra, Inc. to Present at the Wells Fargo 2020 Virtual Healthcare Conference (August 26, 2020)
• Penumbra, Inc. Reports Second Quarter 2020 Financial Results (August 3, 2020)
• Penumbra, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference (July 29, 2020)
• Penumbra, Inc. Schedules Second Quarter 2020 Earnings Release and Conference Call for August 3, 2020 (July 20, 2020)
• Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership (July 14, 2020)
• Penumbra, Inc. to Present at the William Blair 40th Annual Growth Stock Conference (May 29, 2020)
• Penumbra, Inc. Announces Pricing of Offering of Common Stock (May 27, 2020)
• Penumbra, Inc. Announces Launch of Offering of $100,000,000 of Shares of its Common Stock (May 27, 2020)
• Penumbra, Inc. Announces Virtual 2020 Annual Meeting of Stockholders (May 15, 2020)
• Penumbra Announces Management Transition (May 12, 2020)
• Penumbra, Inc. Reports First Quarter 2020 Financial Results (May 7, 2020)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2020 Health Care Conference (April 29, 2020)
• Penumbra, Inc. Schedules First Quarter 2020 Earnings Release and Conference Call for May 7, 2020 (April 23, 2020)
• Penumbra Provides Update on COVID-19 Response and Impact (April 6, 2020)
• International Women's Day 2020 (March 12, 2020)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results (February 25, 2020)
• Employee Spotlight: Meet Joy Backensto (February 25, 2020)
• Health: February is American Heart Month (February 13, 2020)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 25, 2020 (February 11, 2020)
• Meetings & Events: REAL™ Immersive System Debuts at APTA's CSM 2020 (February 10, 2020)
• Employee Spotlight: Meet Jim Lancaster (January 21, 2020)
• Meetings & Events: Penumbra Announces Key Events at ISET 2020 (January 17, 2020)
• Penumbra Announces FDA Clearance of Indigo® Aspiration System for Treatment of Pulmonary Embolism (January 9, 2020)
• Penumbra, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference (December 31, 2019)
• Employee Spotlight: Meet Olaf Beyer (December 10, 2019)
• Maggie Yuen Appointed Chief Financial Officer Of Penumbra (November 25, 2019)
• Meetings & Events: Penumbra Announces Key Events at SVIN 2019 (November 19, 2019)
• Penumbra, Inc. Announces Investor Day 2019 (November 19, 2019)
• Meetings & Events: Penumbra Announces Key Events at VEITHsymposium® (November 15, 2019)
• Penumbra, Inc. Reports Third Quarter 2019 Financial Results (November 7, 2019)
• Penumbra Indigo® Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints (November 6, 2019)
• Employee Spotlight: Meet Phal Cindy Suon (November 5, 2019)
• Meetings & Events: Penumbra Announces Key Events at VIVA 2019 (November 2, 2019)
• Meetings & Events: Penumbra Announces Participation at CNS 2019 (October 26, 2019)
• Penumbra, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 7, 2019 (October 17, 2019)
• Health: Global Campaigns Highlight Thrombosis and Stroke Awareness (October 11, 2019)
• Penumbra Announces First Patient Enrolled in Study of Mechanical Power Aspiration for Thrombus Removal in Coronary Vessels (October 10, 2019)
• Employee Spotlight: Meet Brihony Gills (October 4, 2019)
• Meetings & Events: Penumbra Announces Participation at TCT 2019 (September 20, 2019)
• Sri Kosaraju Promoted to President and CFO of Penumbra (August 29, 2019)
• Penumbra, Inc. to Present at the Morgan Stanley 17th Annual Global Healthcare Conference (August 27, 2019)
• Penumbra, Inc. to Present at the 2019 Wells Fargo Healthcare Conference (August 21, 2019)
• Employee Spotlight: Meet Oliver Carpenter (August 19, 2019)
• Meetings & Events: Penumbra Announces Participation at AMP 2019 (August 12, 2019)
• Penumbra, Inc. Reports Second Quarter 2019 Financial Results (August 6, 2019)
• Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019 (July 22, 2019)
• Meetings & Events: Penumbra Announces Key Events at SNIS 2019 (July 18, 2019)
• Penumbra, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference (July 17, 2019)
• Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 (July 16, 2019)
• Penumbra, Inc. to Present at the BMO 2019 Prescriptions for Success Healthcare Conference (June 11, 2019)
• Employee Spotlight: Meet Danielle Chu (June 5, 2019)
• Penumbra, Inc. to Present at the Goldman Sachs 40th Annual Global Healthcare Conference (May 29, 2019)
• Meetings & Events: Penumbra Announces Participation at SCAI 2019 (May 17, 2019)
• Health: May Highlights Stroke Awareness, High Blood Pressure Education (May 10, 2019)
• Employee Spotlight: Meet Cheryl Binney (May 7, 2019)
• Penumbra, Inc. Reports First Quarter 2019 Financial Results (May 7, 2019)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2019 Health Care Conference (May 1, 2019)
• Penumbra, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 7, 2019 (April 17, 2019)
• Meetings & Events: Penumbra Announces Participation at AANS 2019 (April 11, 2019)
• Meetings & Events: Penumbra Announces Key Events at SIR 2019 (March 22, 2019)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results (February 26, 2019)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 26, 2019 (January 30, 2019)
• Penumbra, Inc. Appoints Janet Leeds and Surbhi Sarna to its Board of Directors (January 18, 2019)
• Penumbra, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference (December 20, 2018)
• Employee Spotlight: Meet Holly Sit (December 11, 2018)
• Penumbra, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference (November 29, 2018)
• Penumbra, Inc. Reports Third Quarter 2018 Financial Results (November 5, 2018)
• Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018 (October 15, 2018)
• Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health (September 4, 2018)
• Penumbra Launches Latest Advancements in Stroke Thrombectomy Aspiration Technology (September 4, 2018)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 22, 2018)
• Penumbra, Inc. Reports Second Quarter 2018 Financial Results (August 7, 2018)
• Penumbra, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference (July 19, 2018)
• Penumbra, Inc. Schedules Second Quarter 2018 Earnings Release and Conference Call for August 7, 2018 (July 17, 2018)
• Penumbra, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference (May 29, 2018)
• Penumbra, Inc. Reports First Quarter 2018 Financial Results (May 8, 2018)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference (May 2, 2018)
• Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018 (April 18, 2018)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results (February 27, 2018)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern Time (January 30, 2018)
• Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke (January 25, 2018)
• Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke (January 25, 2018)
• Penumbra Announces Key Events at International Stroke Conference 2018 Meeting (January 17, 2018)
• Penumbra Announces the Formation of Joint Venture, MVI Health (January 4, 2018)
• Penumbra, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference (December 21, 2017)
• Penumbra, Inc. Reports Third Quarter 2017 Financial Results (November 7, 2017)
• Penumbra, Inc. Schedules Third Quarter 2017 Earnings Release and Conference Call for November 7, 2017 at 5:00 PM Eastern Time (October 24, 2017)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 24, 2017)
• Penumbra, Inc. Reports Second Quarter 2017 Financial Results (August 8, 2017)
• Penumbra, Inc. Schedules Second Quarter 2017 Earnings Release and Conference Call for August 8, 2017 at 4:30 PM Eastern Time (July 25, 2017)
• Penumbra, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference (July 25, 2017)
• Penumbra, Inc. Promotes Daniel Davis to Chief Commercial Officer (July 5, 2017)
• Penumbra, Inc. Reports First Quarter 2017 Financial Results (May 9, 2017)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference (May 3, 2017)
• Penumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference Call for May 9, 2017 at 4:30 PM Eastern Time (April 25, 2017)
• Penumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors (April 21, 2017)
• Penumbra, Inc. Announces Pricing of Offering of 1,300,000 Shares of its Common Stock (March 16, 2017)
• Penumbra, Inc. Announces Launch of Offering of 1,300,000 Shares of its Common Stock (March 15, 2017)
• Penumbra Announces Key Events at Society of Interventional Radiology 2017 Meeting (March 2, 2017)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results (February 28, 2017)
• Independent Study Supports Use of Penumbra Aspiration as Frontline Thrombectomy Therapy for Acute Ischemic Stroke (February 22, 2017)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for February 28, 2017 at 5:00 PM Eastern Time (February 14, 2017)
• Penumbra, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference (December 20, 2016)
• Penumbra, Inc. Appoints Thomas C. Wilder to its Board of Directors (December 19, 2016)
• Penumbra, Inc. Announces Resignation of Board Member (November 15, 2016)
• Penumbra to Highlight Peripheral Vascular Technologies at AIMsymposium and VEITHsymposium in New York (November 10, 2016)
• Penumbra, Inc. Reports Third Quarter 2016 Financial Results (November 3, 2016)
• Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum (October 27, 2016)
• Penumbra, Inc. Schedules Third Quarter 2016 Earnings Release and Conference Call for November 3, 2016 at 5:00 PM Eastern Time (October 20, 2016)
• Penumbra to Highlight Importance of Stroke Treatment at Upcoming Patient Awareness Events (September 27, 2016)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 18, 2016)
• Penumbra, Inc. Reports Second Quarter 2016 Financial Results (August 9, 2016)
• Randomized Penumbra 3D Trial of Next Generation Stent Retriever Meets Primary Endpoints (July 27, 2016)
• Penumbra Launches Newest Stroke Thrombectomy Technology ACE™68 Reperfusion Catheter at SNIS 2016 (July 25, 2016)
• Penumbra Announces Key Events at Society of NeuroInterventional Surgery 2016 Meeting (July 19, 2016)
• Penumbra, Inc. Schedules Second Quarter 2016 Earnings Release and Conference Call for August 9, 2016 at 4:30 PM Eastern Time (July 15, 2016)
• Penumbra, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference (July 15, 2016)
• Penumbra, Inc. Reports First Quarter 2016 Financial Results (May 9, 2016)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference (April 27, 2016)
• Penumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM Eastern Time (April 25, 2016)
• Penumbra to Launch LanternTM Microcatheter, Present Final Results of Multicenter Prism Trial on Indigo® System at SIR 2016 (March 31, 2016)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results (March 8, 2016)
• Penumbra, Inc. Appoints Kevin Sullivan to its Board of Directors (February 23, 2016)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call for March 8, 2016 at 4:30 PM Eastern Time (February 23, 2016)
• Penumbra Introduces POD® Packing Coil for the Embolization of Peripheral Vessels and Aneurysms (January 6, 2016)
• Penumbra, Inc. to Present at the 34th Annual J.P. Morgan 2016 Healthcare Conference (December 28, 2015)
• Penumbra, Inc. Reports Third Quarter 2015 Financial Results (November 12, 2015)
• Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum (November 5, 2015)
• Penumbra, Inc. Schedules Third Quarter 2015 Earnings Release and Conference Call for November 12, 2015 at 4:30 PM Eastern Time (October 30, 2015)
• Penumbra, Inc. Announces Closing of its Initial Public Offering (September 23, 2015)
• Penumbra, Inc. Announces Pricing of Initial Public Offering (September 17, 2015)
• Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients (July 28, 2015)
• Statement from Penumbra, Inc. Regarding American Heart Association/American Stroke Association Guidelines for the Early Management of Patients with Acute Ischemic Stroke (June 29, 2015)
• Penumbra ACE64 Cleared for Marketing by U.S. Food & Drug Administration for Acute Ischemic Stroke Patients (May 27, 2015)
• Sri Kosaraju Joins Penumbra, Inc., as Chief Financial Officer and Head of Strategy (March 3, 2015)
• Penumbra, Inc., to Launch POD™ Embolization Anchoring Device, Present Data on Peripheral Vascular Technologies at the Society of Interventional Radiology 2015 Meeting (February 27, 2015)
• Statement from Penumbra, Inc. Regarding Results of MR CLEAN and Other Studies of Intra-Arterial Treatments at the International Stroke Conference 2015 (February 11, 2015)
• Independent Study Demonstrates Stroke Patients Experience Superior Outcomes with Intra-Arterial Treatment vs. Tissue Plasminogen Activator (tPA) (December 17, 2014)
• Penumbra, Inc. Launches 5MAX™ ACE – The Newest Clot Extraction Device To Treat Acute Ischemic Stroke Patients (July 8, 2013)
• Penumbra, Inc. launches 5MAX™ DDC and 4MAX™ DDC Distal Delivery Catheters (February 4, 2013)
• Penumbra, Inc. Launches New 5MAX™ Reperfusion Catheter (August 22, 2012)
• Know where to go if stroke strikes: Penumbra, Inc. launches QuEST2StopStroke.com (July 17, 2012)
• Penumbra, Inc. Launches the New MAX™ System Reperfusion Catheters for Acute Ischemic Stroke Patients. (June 18, 2012)
• European launch of Penumbra Separator™ 3D announced at the Working Group in Interventional Neuroradiology (WIN) Seminar. (January 23, 2012)